Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal Of Psychopharmacology 2016, 30: 1165-1180. PMID: 27909164, PMCID: PMC5367551, DOI: 10.1177/0269881116675512.Peer-Reviewed Original ResearchConceptsAnti-depressant effectsCancer-related anxietyQuality of lifeCancer-related psychological distressLife-threatening cancerPrimary outcomeCrossover trialTherapeutic effectPsilocybin treatmentSustained benefitMedical outcomesSymptom reductionSignificant anxietyExistential distressPatientsPsychological distressDepressionSpiritual wellbeingCancerAnxietyPsilocybinTrialsOutcomesTreatmentDistress